Available and Emerging Therapies for Progressive/Recurrent ROS1-Altered Advanced NSCLC

Audio podcast with highlights from a live webinar covering available clinical data and approved treatments options for progressive ROS1-altered advanced non-small-cell lung cancer (NSCLC), including emerging options on the horizon. Listen to the experts review and discuss their perspectives and summarize the clinical data in support of guideline second-line and beyond treatments.